Compare GE HealthCare Technologies Inc. Common Stock (GEHC) vs Occidental Petroleum Corporation (OXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
GE HealthCare Technologies Inc. Common Stock vs Occidental Petroleum Corporation — how do they compare? GE HealthCare Technologies Inc. Common Stock trades at $68.5 (market cap $31.07B), while Occidental Petroleum Corporation trades at $61.74 (market cap $61.63B). The key difference: Occidental Petroleum Corporation is the larger of the two by market cap, and Occidental Petroleum Corporation pays the higher dividend (1.82%). Which is the better fit depends on your goals.
| GEHC | OXY | |
|---|---|---|
Market Cap | $31.07B | $61.63B |
Volume | 3,443,020 | 9,180,422 |
Sector | Health | Energy |
52-Week High | $88.16 | $66.24 |
52-Week Low | $59.48 | $38.92 |
Enterprise Value | $39.53B | $80.39B |
Dividend Yield | 0.23% | 1.82% |
Typical Hold Time | — | 92 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GE HealthCare (GEHC) trades at $68.79, up 1.55% today, with a neutral technical signal. The company reported mixed quarterly earnings, beating in Q2 2026 but missing in Q1, and is set to announce Q3 results on October 28, 2026. Recent developments include a $945 million acquisition of SOFIE Biosciences to expand its PET radiopharmaceutical footprint, alongside ongoing securities fraud investigations noted in recent news.
The outlook is cautiously optimistic, supported by a strong analyst consensus with a $79.64 price target and no sell ratings. Key opportunities include growth from strategic acquisitions and AI innovations, while risks involve legal investigations, integration challenges from the SOFIE deal, and potential margin pressures from increased investing cash outflows in 2026.
Occidental Petroleum (OXY) trades at $61.41, up 0.46% with strong technical momentum and bullish moving average signals. The company demonstrates robust profitability with 30.32% net income margin and 21.46% ROE, though revenue has declined from $36.6B in 2022 to $21.6B in 2025. Recent earnings beats and a $71.40 consensus price target suggest upside potential, supported by Goldman Sachs' October 1 upgrade citing cash flow targets and debt reduction plans.
OXY presents a compelling value opportunity with attractive valuation multiples (P/E 18.19, EV/EBITDA 5.66) and strong analyst support (52% buy rating). Key risks include oil price volatility and declining revenue trends, while catalysts include upcoming Q3 earnings and continued operational efficiency improvements. The stock's technical strength and fundamental value create favorable risk-reward dynamics for energy sector exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About GE HealthCare Technologies Inc. Common Stock
GE HealthCare Technologies Inc. is a medical technology company, spun off from General Electric in 2023, that develops imaging systems, ultrasound devices, patient monitoring equipment, and diagnostic imaging agents. Its product lines include CT, MRI, and mammography systems alongside anesthesia delivery and maternal-infant care solutions.
Read more on GEHC →About Occidental Petroleum Corporation
Occidental Petroleum is an independent exploration and production company with operations in the United States, Latin America, and the Middle East. At the end of 2021, the company reported net proved reserves of 3.5 billion barrels of oil equivalent. Net production averaged 1,174 thousand barrels of oil equivalent per day in 2021 at a ratio of 75% oil and natural gas liquids and 25% natural gas.
Read more on OXY →
